Knopp Biosciences Announces Election of Biotech Executive Shane Kovacs to Board of Managers

Knopp Biosciences announced the appointment of Shane Kovacs to its Board of Managers. Kovacs joins the board as the the company initiates advanced clinical development of dexpramipexole in hypereosinophilic syndrome (HES) and eosinophilic asthma. Read more…


Comments are closed.